Mario E. Lacouture

Also affiliated with Island Hospital, New York University Langone Orthopedic Hospital, NYU Grossman Long Island School of Medicine, New York University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 51 papers. Top paper: “First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial”.

First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(23)00358-3

N/A

1.5DataRank · unranked

45 citations

Ryan H. Moy, Darren Cowzer, Ronak Shah, Joanne F. Chou, Smita S. Joshi +25 more

Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers

Investigational New Drugs(2021)10.1007/s10637-020-01035-9

N/A

1.2DataRank · unranked

32 citations

D. Liu, Michael Offin, Cecilia Lezcano, Jean Torrisi, Sheldon L. Brownstein +13 more

Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial

BMJ Open(2020)10.1136/bmjopen-2019-030114

N/A

0.863DataRank · unranked

14 citations

Mike Trower, Ajay Duggal, Pamela Guglielmini, Peter Q. Harris, David M. Jackson +6 more

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003066

N/A

0.628DataRank · unranked

65 citations

Allison Betof Warner, Farzana Y. Zaman, Andrew Haydon, Prachi Bhave, Anna K. Dewan +20 more

Beyond steroids: Immunosuppressants in steroid-refractory/resistant immune related adverse events.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9092

N/A

0.233DataRank · unranked

2 citations

Jason Beattie, Paige Fuentes, Hira Rizvi, Jacklynn V. Egger, Jeffrey A. Kern +8 more

Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines

The Oncologist(2020)10.1002/onco.13552

N/A

0DataRank · unranked

67 citations

V. Sibaud, Milan J. Anadkat, Benjamin H. Kaffenberger, Jonathan S. Leventhal, Kathleen Guindon +2 more

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma

Frontiers in Oncology(2020)10.3389/fonc.2020.01045

N/A

0DataRank · unranked

66 citations

Milan J. Anadkat, Matthew T. Ballo, Fábio M. Iwamoto, Suriya Jeyapalan, Renato V. La Rocca +4 more

Association of interleukin-6 and tumor necrosis factor-α with mortality in hospitalized patients with cancer

Journal of the American Academy of Dermatology(2020)10.1016/j.jaad.2020.03.010

N/A

0DataRank · unranked

17 citations

Toral Vaidya, Shoko Mori, Stephen W. Dusza, Mario E. Lacouture, Alina Markova +1 more

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma

Annals of Clinical and Translational Neurology(2020)10.1002/acn3.51009

N/A

0DataRank · unranked

46 citations

Katherine S. Panageas, Elena Pentsova, Ingo K. Mellinghoff, Craig Nolan, Igor T. Gavrilovic +8 more

Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer

Breast Cancer Research and Treatment(2020)10.1007/s10549-020-05726-y

N/A

0DataRank · unranked

37 citations

Dulce M. Barrios, Victoria Blinder, Jacqueline Bromberg, Pamela Drullinsky, Samuel A. Funt +10 more

The microbial flora of clinically infected cutaneous metastases: a retrospective study

Clinical and Experimental Dermatology(2020)10.1111/ced.14241

N/A

0DataRank · unranked

7 citations

Christopher A. Barker, Mario E. Lacouture, César A. Virgen

Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program

Journal of the American Academy of Dermatology(2020)10.1016/j.jaad.2020.01.059

N/A

0DataRank · unranked

6 citations

Eran C. Gwillim, Cory Kosche, Anna Figueiredo, Corrine Rauck, Stephanie M. Rangel +5 more

Incidence of dermatologic adverse events in patients with cancer treated with concurrent immune checkpoint inhibitors and radiation therapy: A systematic review and meta-analysis

Journal of the American Academy of Dermatology(2020)10.1016/j.jaad.2020.10.071

N/A

0DataRank · unranked

6 citations

Gloria Wasilewski, Mario E. Lacouture, Christopher A. Barker, Bernice Y. Yan

A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013

Journal of Patient-Reported Outcomes(2020)10.1186/s41687-020-00220-x

N/A

0DataRank · unranked

5 citations

Joseph M. Unger, James L. Wade, Lynne I. Wagner, Mario E. Lacouture, Keisha C. Humphries +15 more

Vitiligo Following Autologous Hematopoietic Stem Cell Transplantation

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2019.12.025

N/A

0DataRank · unranked

4 citations

Navdeep Singh, Salma Afifi, Sergio Giralt, Mario E. Lacouture, Klaus J. Busam +2 more

Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1063

N/A

0DataRank · unranked

4 citations

Diana G. Wang, Victoria Blinder, Jacqueline Bromberg, Pamela Drullinsky, Samuel A. Funt +10 more

Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.06.024

N/A

0DataRank · unranked

109 citations

Jason Beattie, Paige Fuentes, Hira Rizvi, Jacklynn V. Egger, Jeffrey A. Kern +8 more

Our current understanding of checkpoint inhibitor therapy in cancer immunotherapy

Annals of Allergy Asthma & Immunology(2021)10.1016/j.anai.2021.03.003

N/A

0DataRank · unranked

60 citations

Taras Lyubchenko, Lukas Kraehenbuehl, Mario E. Lacouture, Donald Y.M. Leung, Jeffrey A. Kern +1 more

Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management

Dermatology and Therapy(2021)10.1007/s13555-021-00624-7

N/A

0DataRank · unranked

44 citations

Kerri E. Rieger, M. Bagot, Jennifer Choi, David C. Fisher, Joan Guitart +11 more

Immune-related cutaneous adverse events due to checkpoint inhibitors

Annals of Allergy Asthma & Immunology(2021)10.1016/j.anai.2021.02.009

N/A

0DataRank · unranked

37 citations

Lukas Kraehenbuehl, Kwami F. Ketosugbo, Jeffrey A. Kern, Mario E. Lacouture, Donald Y.M. Leung +1 more

A multidisciplinary approach to optimizing care of patients treated with alpelisib

The Breast(2021)10.1016/j.breast.2021.12.016

N/A

0DataRank · unranked

26 citations

Mario E. Lacouture, Marcus D. Goncalves, Umesh Masharani, Matti Aapro, Joyce O’Shaughnessy +1 more

Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1847

N/A

0DataRank · unranked

25 citations

Zev A. Wainberg, Anisha B. Patel, Milan J. Anadkat, Salomon M. Stemmer, Einat Shacham‐Shmueli +5 more

Dermatologic infections in cancer patients treated with checkpoint inhibitors

Journal of the American Academy of Dermatology(2021)10.1016/j.jaad.2021.03.039

N/A

0DataRank · unranked

8 citations

Dulce M. Barrios, Gregory S. Phillips, Michael A. Postow, Allison Betof Warner, Jonathan E. Rosenberg +4 more

Quality of life before and after treatment of cutaneous metastases with palliative radiotherapy

Journal of the American Academy of Dermatology(2021)10.1016/j.jaad.2021.11.026

N/A

0DataRank · unranked

6 citations

Brooke E. Corbett, Nina R. Blank, Rachel A. Day, Michael J. McManus, Jennifer Ma +5 more

Corrigendum to ‘SJS/TEN 2019: From science to translation’ [J. Dermatol. Sci. 98/1 (2020) 2–12]

Journal of Dermatological Science(2021)10.1016/j.jdermsci.2021.09.008

N/A

0DataRank · unranked

2 citations

Riichiro Abe, Paul Anderson, Wanpen Anderson, Michael R. Ardern‐Jones, Thomas M. Beachkofsky +65 more

Comparison of checkpoint inhibitor treatment-related cutaneous adverse events in racial and ethnic minority and Caucasian cohorts at Memorial Sloan Kettering Cancer Center.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2632

N/A

0DataRank · unranked

1 citations

Dulce M. Barrios, Gregory Phillips, Rosa Nouvini, Mario E. Lacouture, Sarah Noor +1 more

Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.02.004

N/A

0DataRank · unranked

57 citations

Christian Rolfo, Alexander Drilon, Mario E. Lacouture, Benjamin Besse, Kōichi Goto +10 more

Ibrutinib-associated dermatologic toxicities: A systematic review and meta-analysis

Critical Reviews in Oncology/Hematology(2022)10.1016/j.critrevonc.2022.103696

N/A

0DataRank · unranked

19 citations

Tyler M. Andriano, Arpita Bose, Marina Chilov, Kendra Godwin, George Dranitsaris +6 more

Dermatologist awareness of scalp cooling for chemotherapy-induced alopecia

Journal of the American Academy of Dermatology(2022)10.1016/j.jaad.2022.03.009

N/A

0DataRank · unranked

8 citations

Elizabeth J. Klein, Katerina Svigos, Taylor Novice, Daniel Gutiérrez, Ruth Oratz +6 more

Shared decision making for patients with breast and gynecologic malignancies undergoing chemotherapy associated with persistent alopecia

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101095

N/A

0DataRank · unranked

4 citations

Anastasia Navitski, Claire F. Friedman, Donald Chan, Shari Goldfarb, Mario E. Lacouture +2 more

Non‐invasive, in vivo, characterization of cutaneous metastases using a novel multimodal RCM‐OCT imaging device: a case‐series

Journal of the European Academy of Dermatology and Venereology(2022)10.1111/jdv.18344

N/A

0DataRank · unranked

7 citations

Jilliana Monnier, Ucalene Harris, Jason Garfinkel, Gennady Rubinstein, Nicusor Iftimia +5 more

Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor–positive breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12100

N/A

0DataRank · unranked

2 citations

Alexander Pan, George Dranitsaris, Ucalene Harris, Sarat Chandarlapaty, Chau T. Dang +11 more

Management of immune-related cutaneous adverse events with dupilumab

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007324

N/A

0DataRank · unranked

51 citations

Stephanie Gu, Joseph R. Stoll, Andrea P. Moy, Stephen W. Dusza, Allison Gordon +8 more

Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms

British Journal of Haematology(2023)10.1111/bjh.18964

N/A

0DataRank · unranked

22 citations

Benjamin H. Durham, Mariko Yabe, Kseniya Petrova‐Drus, Jasmine H. Francis, Raajit K. Rampal +6 more

CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition

Leukemia(2023)10.1038/s41375-023-01947-4

N/A

0DataRank · unranked

10 citations

Jasmine H. Francis, Mario E. Lacouture, Veronica Rotemberg, Mariko Yabe, Kseniya Petrova‐Drus +5 more

Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region

Frontiers in Oncology(2023)10.3389/fonc.2022.975473

N/A

0DataRank · unranked

15 citations

Mario E. Lacouture, Adam Friedman, Zachary D. Horne, Jae U. Jung, Benjamin H. Kaffenberger +6 more

PRO-CTCAE reveals under-recognition of dermatologic symptom burden in hospitalized cancer patients

Supportive Care in Cancer(2023)10.1007/s00520-023-07793-5

N/A

0DataRank · unranked

5 citations

Christian Menzer, Jennifer L. Hay, Camila Peña, Stephen W. Dusza, Mario E. Lacouture +2 more

Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07143-3

N/A

0DataRank · unranked

4 citations

Stephen W. Dusza, Elizabeth Quigley, Helen Haliasos, Alina Markova, Michael A. Marchetti +7 more

Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer Patients

Research Square(2023)10.21203/rs.3.rs-2679676/v1

N/A

0DataRank · unranked

0 citations

Stephen W. Dusza, Elizabeth Quigley, Helen Haliasos, Alina Markova, Michael A. Marchetti +7 more

Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3431

N/A

0DataRank · unranked

32 citations

Elena Goleva, Neil J. Shah, Veronica Rotemberg, Lukas Kraehenbuehl, Kwami F. Ketosugbo +15 more

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007675

N/A

0DataRank · unranked

27 citations

Yevgeniy R. Semenov, Allireza Alloo, Daniel Q. Bach, Allison Betof Warner, Amina Bougrine +36 more

Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy

British Journal of Haematology(2024)10.1111/bjh.19462

N/A

0DataRank · unranked

16 citations

Benjamin H. Durham, Anne S. Reiner, Mariko Yabe, Kseniya Petrova‐Drus, Ahmet Doǧan +26 more

Clinical presentations of skin of color in oncodermatology

Journal of the American Academy of Dermatology(2024)10.1016/j.jaad.2024.08.060

N/A

0DataRank · unranked

1 citations

Leore Lavin, Alina Markova, Mario E. Lacouture, Anna Chen

Phenotype/Immunologic Profiling in ircAEs—Response

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2949

N/A

0DataRank · unranked

0 citations

Mario E. Lacouture, Andrea P. Moy, Jeffrey A. Kern, Donald Y.M. Leung, Elena Goleva

Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292)

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100792

N/A

0DataRank · unranked

3 citations

Rose Parisi, Guilherme Harada, Andrea P. Moy, George Dranitsaris, Jasmine H. Francis +7 more

Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆

Annals of Oncology(2020)10.1016/j.annonc.2020.11.005

N/A

0DataRank · unranked

173 citations

V. Sibaud, Peter Arne Gerber, Corina van den Hurk, Pablo Fernández‐Peñas, Daniele Santini +3 more

No serum estradiol changes with 5-alpha reductase inhibitors for late alopecia in cancer survivors: A retrospective cohort study

Journal of the American Academy of Dermatology(2025)10.1016/j.jaad.2025.11.076

N/A

0DataRank · unranked

0 citations

Lavanya Mittal, Mario E. Lacouture, Stephen W. Dusza, Allison Gordon, Jacqueline Bromberg +5 more

Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features

Journal of the American Academy of Dermatology(2020)10.1016/j.jaad.2020.04.105

N/A

0DataRank · unranked

170 citations

Aren T. Vierra, Jillian Wong Millsop, Mario E. Lacouture, Maija Kiuru, Samantha R. Ellis

Immune checkpoint inhibitor–related dermatologic adverse events

Journal of the American Academy of Dermatology(2020)10.1016/j.jaad.2020.03.132

N/A

0DataRank · unranked

466 citations

Gregory S. Phillips, Dulce M. Barrios, Jennifer Wu, Donald Y.M. Leung, Andrea P. Moy +3 more

Immune checkpoint inhibitors to treat cutaneous malignancies

Journal of the American Academy of Dermatology(2020)10.1016/j.jaad.2020.03.131

N/A

0DataRank · unranked

92 citations

H. Mytrang, Gregory S. Phillips, Michael A. Postow, Tomoko Akaike, Paul Nghiem +2 more

SJS/TEN 2019: From science to translation

Journal of Dermatological Science(2020)10.1016/j.jdermsci.2020.02.003

N/A

0DataRank · unranked

76 citations

Riichiro Abe, Paul Anderson, Wanpen Anderson, Michael R. Ardern‐Jones, Thomas M. Beachkofsky +65 more